Suchergebnisse - "Su, Dongyuan"

PubPharm (6)

1

EPIC-0628 abrogates HOTAIR/EZH2 interaction and enhances the temozolomide efficacy via promoting ATF3 expression and inhibiting DNA damage repair in glioblastoma

enthalten in: Cancer letters | 2024

von Yang, E. | Hong, B. | Wang, Y. | +8

2

EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma

enthalten in: Neuro-oncology | 2024

von Hong, B. | Yang, E. | Su, D. | +15

ErratumIn: Neuro Oncol. 2023 Dec 8;25(12):2306-2308. - PMID 37931238

3

Ameliorative effect of Magnesium Isoglycyrrhizinate on hepatic encephalopathy by Epirubicin

enthalten in: International immunopharmacology | 2019

von Jiang, W. | Guo, H. | Su, D. | +3

4

Design, synthesis and biological evaluation of 4-aniline-thieno[2,3-d]pyrimidine derivatives as MNK1 inhibitors against renal cell carcinoma and nasopharyngeal carcinoma

enthalten in: Bioorganic & medicinal chemistry | 2019

von Zhang, M. | Jiang, L. | Tao, J. | +5

5

Deletion of aquaporin-4 aggravates brain pathology after blocking of the meningeal lymphatic drainage

enthalten in: Brain research bulletin | 2018

von Cao, X. | Xu, H. | Feng, W. | +2

6

Synthesis, antitumor activity and molecular mechanism of doxorubicin conjugated trimethyl-chitosan polymeric micelle loading Beclin1 siRNA for drug-resisted bladder cancer therapy

enthalten in: RSC advances | 2018

von Zhong, Z. | Cheng, Z. | Su, D. | +3

1
[1]